Identification of novel cellular targets in biliary tract cancers using global gene expression technology.

[1]  Jeffrey,et al.  5-a-Reductase Inhibition and Prostate Cancer Prevention ” , 2005 .

[2]  Masao Tanaka,et al.  Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro , 2004, Clinical & Experimental Metastasis.

[3]  A. Chen,et al.  Phase I clinical trial of continuous infusion cyclopentenyl cytosine , 2004, Cancer Chemotherapy and Pharmacology.

[4]  M. Vallée,et al.  Isolation of Differentially Expressed Genes in , 2003 .

[5]  E. Ariazi,et al.  Estrogen-related Receptor α and Estrogen-related Receptor γ Associate with Unfavorable and Favorable Biomarkers, Respectively, in Human Breast Cancer , 2002 .

[6]  Scott E Kern,et al.  Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. , 2002, The American journal of pathology.

[7]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[8]  P. Trempat,et al.  Isolation of differentially expressed genes in NPM‐ALK‐positive anaplastic large cell lymphoma , 2002, British journal of haematology.

[9]  K. Fransén,et al.  Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas. , 2002, Cancer letters.

[10]  J. Shelhamer,et al.  Involvement of 85‐kd cytosolic phospholipase A2 and cyclooxygenase‐2 in the proliferation of human cholangiocarcinoma cells , 2002, Hepatology.

[11]  W-H Kim,et al.  Establishment and characterisation of six human biliary tract cancer cell lines , 2002, British Journal of Cancer.

[12]  J. Kutok,et al.  Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. , 2002, The American journal of pathology.

[13]  V. Giguère.  To ERR in the estrogen pathway , 2002, Trends in Endocrinology & Metabolism.

[14]  D. Altieri,et al.  A p34(cdc2) survival checkpoint in cancer. , 2002, Cancer cell.

[15]  Jing Yin,et al.  Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. , 2002, Cancer research.

[16]  Kai-Florian Storch,et al.  Extensive and divergent circadian gene expression in liver and heart , 2002, Nature.

[17]  D. Larsimont,et al.  HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Kimberly Walter,et al.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. , 2002, The American journal of pathology.

[19]  G. Gores,et al.  Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. , 2002, Gastroenterology.

[20]  L. Trusolino,et al.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth , 2002, Nature Reviews Cancer.

[21]  H. Preisler,et al.  Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Barbacid,et al.  Cyclin D-dependent kinases, INK4 inhibitors and cancer. , 2002, Biochimica et biophysica acta.

[23]  P. Lollini,et al.  Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells , 2002, Cancer Gene Therapy.

[24]  R. Salgia,et al.  Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. , 2002, Cytokine & growth factor reviews.

[25]  Jiang Shou,et al.  Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA , 2002, Oncogene.

[26]  Arnab Chakravarti,et al.  Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. , 2002, Cancer research.

[27]  R. Hruban,et al.  Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.

[28]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Herlyn,et al.  Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development , 2001, Oncogene.

[30]  J. Deddens,et al.  Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Wistuba,et al.  Epidemiology and Molecular Pathology of Gallbladder Cancer , 2001, CA: a cancer journal for clinicians.

[33]  C. Webb,et al.  Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors. , 2001, Anticancer research.

[34]  W F Bodmer,et al.  Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. , 2001, American journal of human genetics.

[35]  M. Monden,et al.  Differential expression of cyclooxygenase‐2 (COX‐2) in human bile duct epithelial cells and bile duct neoplasm , 2001, Hepatology.

[36]  V. Giguère,et al.  4-Hydroxytamoxifen Is an Isoform-Specific Inhibitor of Orphan Estrogen-Receptor-Related (ERR) Nuclear Receptors β and γ. , 2001, Endocrinology.

[37]  A. Carè,et al.  HOXB7: a key factor for tumor-associated angiogenic switch. , 2001, Cancer research.

[38]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[39]  Cheng Li,et al.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.

[40]  S. Deventer,et al.  Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. , 2001, Gastroenterology.

[41]  Michael D. Schneider,et al.  Transforming Growth Factor-β Receptor-associated Protein 1 Is a Smad4 Chaperone* , 2001, The Journal of Biological Chemistry.

[42]  M. Steffen,et al.  Motility factors identified in supernatants of human cholangiocarcinoma cell lines. , 2001, International journal of oncology.

[43]  N. Normanno,et al.  The role of EGF-related peptides in tumor growth. , 2001, Frontiers in bioscience : a journal and virtual library.

[44]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Humphrey,et al.  Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer. , 2001, The Journal of urology.

[46]  A. Sirica,et al.  Biliary cancer growth factor pathways, cyclo‐oxygenase‐2 and potential therapeutic strategies , 2001, Journal of gastroenterology and hepatology.

[47]  R. Roden,et al.  A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Vogt,et al.  A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  V. Giguère,et al.  4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma. , 2001, Endocrinology.

[50]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[51]  A. Carè,et al.  HOXB 7 : A Key Factor for Tumor-associated Angiogenic Switch 1 , 2001 .

[52]  M. Hidalgo,et al.  The rapamycin-sensitive signal transduction pathway as a target for cancer therapy , 2000, Oncogene.

[53]  S. Thung,et al.  Expression of p53 and PCNA in Cholangiocarcinoma and Primary Sclerosing Cholangitis , 2000, Modern Pathology.

[54]  Hui Zhang,et al.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Mohammad,et al.  Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. , 2000, Cancer research.

[56]  T. Rohan,et al.  Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.

[57]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[58]  J. Lunz,et al.  Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor β1, and activin a: Comparison of a cholangiocarcinoma cell line with primary cultures of non‐neoplastic biliary epithelial cells , 2000, Hepatology.

[59]  P. Casellas,et al.  Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors , 2000, British Journal of Cancer.

[60]  H. Nakamura,et al.  Control of chick tectum territory along dorsoventral axis by Sonic hedgehog. , 2000, Development.

[61]  D. J. Heard,et al.  Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. , 2000, Molecular endocrinology.

[62]  A. Hongo,et al.  Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. , 2000, Cancer research.

[63]  K. Kinzler,et al.  Going mad with Smads. , 1999, The New England journal of medicine.

[64]  G. Gores,et al.  Biliary tract cancers. , 1999, The New England journal of medicine.

[65]  J. Minna,et al.  Enrichment of epithelial cells for molecular studies , 1999, Nature Medicine.

[66]  Q. Li,et al.  Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. , 1999, In vivo.

[67]  J. Dichgans,et al.  Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. , 1999, European journal of pharmacology.

[68]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  P. Ferrara,et al.  Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. , 1998, European journal of biochemistry.

[70]  T. Tsuji,et al.  Transforming Growth Factor-β1 Stimulates or Inhibits Cell Growth via Down- or Up-Regulation of p21/Waf1 , 1998 .

[71]  Y. Paik,et al.  Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen. , 1998, Molecules and cells.

[72]  G. Skouteris,et al.  Cytosolic phospholipase A2 is activated by the hepatocyte growth factor receptor-kinase in Madin Darby canine kidney cells. , 1997, Journal of cell science.

[73]  I. Takata,et al.  Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients. , 1997, Lung cancer.

[74]  W. Plunkett,et al.  Gemcitabine: preclinical pharmacology and mechanisms of action. , 1996, Seminars in oncology.

[75]  H. Nishino,et al.  [Effect of recombinant human basic fibroblast growth factor (bFGF) on the growth of human tumor cell lines]. , 1996, Human Cell.

[76]  J. Gurney,et al.  Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. , 1996, Blood.

[77]  T. Kudo,et al.  Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. , 1995, The Tohoku journal of experimental medicine.

[78]  D. Drucker,et al.  The LIM Domain Homeobox Gene isl-1 Is a Positive Regulator of Islet Cell-specific Proglucagon Gene Transcription(*) , 1995, The Journal of Biological Chemistry.

[79]  E. Dennis.  Diversity of group types, regulation, and function of phospholipase A2. , 1994, The Journal of biological chemistry.

[80]  B. Kramer,et al.  5-Alpha-reductase inhibition and prostate cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[81]  D. Henson,et al.  Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates , 1992, Cancer.

[82]  D. Corle,et al.  Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates , 1992, Cancer.

[83]  J. Wang,et al.  Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[84]  P. Nurse,et al.  Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein , 1988, Nature.

[85]  T. Sargent.  Isolation of differentially expressed genes. , 1987, Methods in enzymology.